Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Collapse authors list.
Folegatti, Pedro M, Ewer, Katie J, Aley, Parvinder K, Angus, Brian, Becker, Stephan, Belij-Rammerstorfer, Sandra, Bellamy, Duncan, Bibi, Sagida, Bittaye, Mustapha, Clutterbuck, Elizabeth A et al (show 23 more authors) , Dold, Christina, Faust, Saul N, Finn, Adam, Flaxman, Amy L, Hallis, Bassam, Heath, Paul, Jenkin, Daniel, Lazarus, Rajeka, Makinson, Rebecca, Minassian, Angela M, Pollock, Katrina M, Ramasamy, Maheshi, Robinson, Hannah, Snape, Matthew, Tarrant, Richard, Voysey, Merryn, Green, Catherine, Douglas, Alexander D, Hill, Adrian VS, Lambe, Teresa, Gilbert, Sarah C, Pollard, Andrew J and Grp, Oxford COVID Vaccine Trial (2020) Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. LANCET, 396 (10249). 467 - 478.

Access the full-text of this item by clicking on the Open Access link.

Item Type:	Article
Depositing User:	Symplectic Admin
Date Deposited:	06 Oct 2020 15:06
Last Modified:	19 May 2022 02:14
DOI:	10.1016/S0140-6736(20)31604-4
Open Access URL:	https://doi.org/10.1016/S0140-6736(20)31604-4
Related URLs:	Author
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3103769